153 related articles for article (PubMed ID: 15802303)
1. Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells.
van Vliet SJ; van Liempt E; Saeland E; Aarnoudse CA; Appelmelk B; Irimura T; Geijtenbeek TB; Blixt O; Alvarez R; van Die I; van Kooyk Y
Int Immunol; 2005 May; 17(5):661-9. PubMed ID: 15802303
[TBL] [Abstract][Full Text] [Related]
2. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
Tumoglu B; Keelaghan A; Avci FY
Glycobiology; 2023 Dec; 33(11):879-887. PubMed ID: 37847609
[TBL] [Abstract][Full Text] [Related]
3. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
5. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties.
Singh SK; Streng-Ouwehand I; Litjens M; Weelij DR; García-Vallejo JJ; van Vliet SJ; Saeland E; van Kooyk Y
Mol Immunol; 2009 Mar; 46(6):1240-9. PubMed ID: 19162326
[TBL] [Abstract][Full Text] [Related]
6. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis.
Saba K; Denda-Nagai K; Irimura T
Am J Pathol; 2009 Jan; 174(1):144-52. PubMed ID: 19095961
[TBL] [Abstract][Full Text] [Related]
7. Sweet preferences of MGL: carbohydrate specificity and function.
van Vliet SJ; Saeland E; van Kooyk Y
Trends Immunol; 2008 Feb; 29(2):83-90. PubMed ID: 18249034
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL).
Mortezai N; Behnken HN; Kurze AK; Ludewig P; Buck F; Meyer B; Wagener C
Glycobiology; 2013 Jul; 23(7):844-52. PubMed ID: 23507963
[TBL] [Abstract][Full Text] [Related]
9. Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.
Napoletano C; Zizzari IG; Rughetti A; Rahimi H; Irimura T; Clausen H; Wandall HH; Belleudi F; Bellati F; Pierelli L; Frati L; Nuti M
Eur J Immunol; 2012 Apr; 42(4):936-45. PubMed ID: 22531918
[TBL] [Abstract][Full Text] [Related]
10. The C-type lectin-like domain superfamily.
Zelensky AN; Gready JE
FEBS J; 2005 Dec; 272(24):6179-217. PubMed ID: 16336259
[TBL] [Abstract][Full Text] [Related]
11. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
[TBL] [Abstract][Full Text] [Related]
12. Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy.
Prasse N; Wessolowski C; Müller I; Cornils K; Franke AK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791381
[TBL] [Abstract][Full Text] [Related]
13. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design.
Clemente B; Denis M; Silveira CP; Schiavetti F; Brazzoli M; Stranges D
Front Immunol; 2023; 14():1294929. PubMed ID: 38090568
[TBL] [Abstract][Full Text] [Related]
14. Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System.
Szczykutowicz J
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069400
[TBL] [Abstract][Full Text] [Related]
15. Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.
Wijfjes Z; van Dalen FJ; Le Gall CM; Verdoes M
Mol Pharm; 2023 Oct; 20(10):4826-4847. PubMed ID: 37721387
[TBL] [Abstract][Full Text] [Related]
16. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
[TBL] [Abstract][Full Text] [Related]
17. Life stage-specific glycosylation of extracellular vesicles from
Kuipers ME; Nguyen DL; van Diepen A; Mes L; Bos E; Koning RI; Nolte-'t Hoen ENM; Smits HH; Hokke CH
Front Mol Biosci; 2023; 10():1125438. PubMed ID: 37006612
[TBL] [Abstract][Full Text] [Related]
18. Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.
Makandar AI; Jain M; Yuba E; Sethi G; Gupta RK
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560459
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
